The Health Care Select Sector SPDR® Fund Newsroom

AbbVie Unusual Options Activity

Benzinga4minutes ago

Pharma Stocks Gain as Traders Have Doubts on Trump's Executive Order to Lower Drug Prices

MarketWatch55minutes ago

Cigna, CVS Down as Trump Targets 'Drug Middlemen' in Drug Prices EO

Seeking AlphaMay 12 11:15 ET

Congressional Trading Report: Rep. Jared Moskowitz Bought Over $27K In AbbVie Stock

BenzingaMay 12 11:00 ET

Roche Plans $700M North Carolina Facility

Seeking AlphaMay 12 10:53 ET

Express News | President Trump Says U.S. Will Pay Same As Other Countries For Drugs; Republicans Can Do Better Than Obamacare; Drug Prices Will Affect Budget Deal; Will Cut Out Middlemen In Drug Sales; Will Help Drug Companies With Other Nations; Will Open Up U.S....

BenzingaMay 12 10:24 ET

Express News | President Trump Says EU Will Have To Pay More For Healthcare, We're Going To Have To Pay Less; Some Countries In Dire Need Might Be Helped Under Drug Policy

BenzingaMay 12 10:15 ET

Innovation, Pharma Profits Won't Suffer Under Trump Prescription Drug EO - White House

Seeking AlphaMay 12 10:00 ET

Trump's Drug Price Cuts: Will They Work?

Moomoo News GlobalMay 12 09:35 ET

Sector Update: Health Care Stocks Advance Premarket Monday

MT NewswiresMay 12 09:20 ET

Leading And Lagging Sectors For May 12, 2025

BenzingaMay 12 09:10 ET

'Trump To Sign Order To Cut Some U.S. Drug Prices To Match Those Abroad' - CNBC

BenzingaMay 12 09:00 ET

Today's Pre-Market Movers and Top Ratings | TSLA, NVDA, LLY and More

Movers and ShakersMay 12 08:29 ET

Mark Cuban Slams Charlie Kirk Over Drug Price Debate, Says PBMs — Not Big Pharma — Are The Real Villains: 'For Your Company...Ask Your PBM For A List Of Claims'

BenzingaMay 12 07:40 ET

Eli Lilly and Co is directly competing with Novo-Nordisk A/S! The weight loss effect of Zepbound is far better than Wegovy.

① Eli Lilly and Co's weight loss drug Zepbound has a weight loss effect almost 50% greater than Novo-Nordisk A/S's Wegovy. After 72 weeks of treatment, patients in the Zepbound group lost an average of 50 pounds, while those in the Wegovy group lost 33 pounds; ② Although Zepbound shows better weight loss effects, both drugs are important for treating obesity, which affects approximately 40% of adults in the USA.

cls.cnMay 12 05:23 ET

Biggest Stock Movers Monday: Magnificent Seven, and More

Seeking AlphaMay 12 05:11 ET

Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial

BenzingaMay 12 04:03 ET

Reported Earlier, Zepbound (Tirzepatide) Outperforms Wegovy In Head-To-Head Study, Delivering Over 20% Average Weight Loss Over 72 Weeks

BenzingaMay 12 03:00 ET

Trump Vows to Cut Drug Prices in the U.S. by up to 80%

Seeking AlphaMay 12 02:07 ET

Asian Healthcare Stocks Drop as Trump Eyes Lower Drug Costs

Seeking AlphaMay 12 01:46 ET